Overview

  • Product nameL-DOPA
  • Description
    Dopamine (ab120565) precursor
  • Alternative names
    • Levodopa
  • Biological descriptionDopamine (ab120565) precursor. Blood-brain barrier permeable. Increases dopamine levels in Parkinson's disease models to display anti-Parkinson's disease properties.
  • Purity> 99%

Properties

    Associated products

    References for L-DOPA (ab120573)

    This product has been referenced in:
    • Ahmed MR  et al. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med 2:28ra28 (2010). Read more (PubMed: 20410529) »
    • Pisani A & Shen J Levodopa-induced dyskinesia and striatal signaling pathways. Proc Natl Acad Sci U S A 106:2973-4 (2009). Read more (PubMed: 19251671) »
    • Muñoz A  et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain 131:3380-94 (2008). Read more (PubMed: 18952677) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120573.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"